Delivery Order SPE2DB24D3013-SPE2DB26FFGEB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens with a ceiling value of $12,064.81. This competitive, non-set-aside delivery order is set to be completed by October 27, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pens valued at $10,961.03 on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a ceiling value of $3,434.34. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and represents a non-competitive set-aside transaction. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a delivery order valued at $9,840.04 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on June 17, 2025, with an ultimate completion date of June 18, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,344.41 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a branded pharmaceutical product used in diabetes management,...
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,681.38 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price delivery order requires fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania location and represents no set-aside designation. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's role...
- The Defense Logistics Agency awarded a $71,465.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGEBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on November 5, 2025, with a ceiling value of $3,130.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains significant federal procurement relationships and has demonstrated capability to fulfill competitive requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/5/25 |